Sept 16, 2014:
Congratulations to Dr. Sailen Barik for receiving a three-year R15 NIH grant award totaling $436,500. The grant is entitled "Structure and function of RNA viral interferon suppressor complexes". The long-term goal of this project is to decipher how RNA viruses suppress the host's innate immune response. The short-term goal is to glean a biochemical and mechanistic understanding how the two unique nonstructural (NS) proteins of respiratory syncytial virus (RSV) operate to suppress both the induction and function of type I interferon (IFN), which enables the virus to cause severe lower respiratory tract infection and associated mortality.
Aug 18, 2014:
Aug 1, 2014:
Dr. Anton A. Komar has received a three-year R15 NIH grant award totaling $436,500. The grant is entitled "Understanding the impact of disease causing mutations in FIX" and will further help Dr. Komar to enhance his work on understanding the molecular mechanisms behind several disease causing synonymous mutations leading to Hemophilia B.
July 2, 2014:
Dr. Aaron Severson has been selected to present a talk at the prestigious Gordon Research Conference on Genomic Instability and “Mechanisms That Cause DNA Damage and Related Diseases” to be held in Hong Kong, China, July 6-11, 2014. The title of his talk "Establishing and Releasing Cohesion During Meiosis". Congratulations, Aaron!
The Gordon Research Conferences provide an international forum for the presentation and discussion of frontier research in the biological, chemical, and physical sciences, and their related technologies. For over 75 years, GRC's high-quality, cost-effective meetings have been recognized as the world's premier scientific conferences, where leading investigators from around the globe discuss their latest work and future challenges in a uniquely informal, interactive format.
June 5, 2014:
Congratulations to Dr. Anthony J. Berdis a member of GRHD and the Founder and Chief Scientific Officer of Red5 Pharmaceuticals LLC. Red5 Pharmaceuticals LLC has just received Northeast Ohio’s Innovation Fund Award totaling $25,000 that will help Dr. Berdis to develop novel diagnostic assays enabling a personalized medicine approach to chemotherapy of cancer patients. The Innovation Fund supports early-stage technology-based startups. On June 3, 2014 it has announced (in its latest funding round) five awards totaling $275,000. Three companies received $25,000 awards aimed at validating technologies and two received $100,000 awards meant to prove out business concepts.
May 28, 2014:
Congratulations to Dr. Xue-Long Sun, for winning a 2-year American Heart Association (AHA) Grant-in-Aid award for his proposal “Recombinant Thrombomodulin Glycoconjugate and Its Antithrombotic Activity.” Dr. Sun is an expert in glyco-affinity ligand engineering and targeted drug delivery applications. Dr. Sun is a member of GRHD faculty since 2009. He joined CSU in 2006 after completing his training at Emory University School of Medicine.
May 15, 2014:
Congratulations to Dr. Valentin Börner, for winning the Faculty Research and Development (FRD) award for his proposal "Role of the proteasome in chromosome stability."
Dr. Börner is a member of GRHD faculty since GRHD inception in 2008. He joined CSU in 2005 after completing post-doctoral training at Harvard University.
May 5, 2014:
GRHD receives donations from Fisher Scientific and its vendors to support GRHD Graduate Progress Report Seminar Series. We thank Christina Camuendo (Fisher Sci), Charlie Fink (Fisher Safety), Tricia Tortoreti (Thermo Sci Lab Equipment), Kholiswa Laird (Thermo Sci Manual Liquid Handling), Scott Wisniewski (Thermo Sci Nalge Nunc), Bob Myers (Thermo Sci Chromagraphy Consumables), Joshua Schaefer (Mettler Toledo), Eric Tepe (Sartorius), Christopher Yarima (Millipore Water), Bikram Chakraborty (Biotek), Michael Hutsell (GE Healthcare) for their support.
April 30, 2014:
April 15, 2014:
Congratulations to Dr. Michael Kalafatis, who recently received a three-year unrestricted grant from the Parker Foundation in the amount of $1.2 million to support his innovative research on cancer therapy. Dr. Kalafatis is a co-founding member of GRHD and member of the GRHD planning committee.
April 15, 2014:
Congratulations to Dr. Andrew Resnick, for wining the second Faculty Innovation Fund (FIF) award for his proposal, "Microperfusion Tissue Interrogator: platform technology development."
Dr. Resnick joined GRHD faculty in 2011. He is currently the only GRHD faculty representing Department of Physics at CSU.
April 3, 2014:
A pledge of $50,000 was made by Dr. John C. Vitullo to support pilot and innovative research projects at the Center for Gene Regulation in Health and Disease (GRHD). Dr. Vitullo was the COSHP college's 2013 Distinguished Alumni Award recipient. He holds a master's degree from Youngstown State University and a Ph.D. (1984) in Regulatory Biology from Cleveland State University. He is chief executive officer and co-founder of Omega Laboratories, Inc., one of only a few hair drug-testing laboratories in the world.
March 17, 2014:
Congratulations to Dr. Girish Shukla, who recently received notification of funding from the Department of Defense (DoD) for two grant proposals for his research on prostate cancer. Dr. Shukla's grants are Exploration - Hypothesis Development Awards from the DoD's Prostate Cancer Research Program. In addition to Dr. Shukla, these grants were awarded to faculty from distinguished research universities, including Stanford University, UCLA, and George Washington University. Furthermore, CSU was the only university with two funded awards.
January 31, 2014:
Congratulation to Dr. Anthony Berdis, who has earned the distinction of having received CSU’s first-ever Faculty Innovation Fund (FIF) award for his proposal “Diagnostic Kits to Quantify Pro-Mutagenic Replication in Hyperproliferative Diseases.” Dr. Berdis joined GRHD faculty in 2012. His research spans several fields ranging from chemistry to biochemistry and cancer pharmacology.
January 8, 2014:
Dr. Anton A. Komar has been appointed new director of the Center for Gene Regulation in Health and Disease (GRHD).
Dr. Komar joined the CSU faculty in 2005. He is a co-founding member of GRHD.
June 15, 2013:
Two Ph.D. students of GRHD member Dr. Michael Kalafatis presented their recent discoveries on the blood coagulation Factor V in major national and international conferences.
Joesph R. Wiencek has been selected by the American Association for Clinical Chemistry for the highly competitive $2,500 travel award to attend the 2013 AACC Annual Meeting in Houston, TX. Joe's work has also been selected for an oral presentation at the XXIV Congress of the International Society on Thrombosis and Haemostasis, in Amsterdam, the Netherlands from June 29 to July 4, 2013. Joe has also another eposter presentation at the same meeting. Mahesheema Na, another PhD student in Dr. Kalafatis' group, is also presenting two studies in the same meeting: one oral presentation and an eposter
. These studies offer important insights into the function of Factor V, deficiency in which leads to predisposition for hemorrhage, while some mutations (notably, Factor V Leiden) predispose for thrombosis. Our congratulations to Joe, Sheema and Dr. Kalafatis.
June 3, 2013:
Sujata Jha, a PhD student of Dr. Anton A. Komar, has been selected for oral presentation of her research at the EMBO conference, 'The Biology of Molecular Chaperones', 17 – 22 May 2013, Santa Margherita di Pula, Italy.
Our congratulations to Sujata, and to Dr. Komar! The Conference home page is here: http://events.embo.org/13-chaperone
May 29, 2013:
Congratulations to GRHD member Dr. Anton A. Komar for winning a 2-year American Heart Association Grant-in-Aid award on "Comparative study of nonsynonymous and synonymous mutations causing hemophilia B".
Dr. Komar is a renowned expert in multiple aspects of translational regulation, including co-translational protein folding and single nucleotide polymorphisms (SNPs).
Janunary 28 2013:
Congratulations to GRHD member Dr. Bin Su for receiving an NIH AREA award (R15) titled "Drug development of orally active anti-trypanosomiasis agents".
Dr. Su is a medicinal chemist focusing on anti-cancer and anti-parasite drug development. African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease caused by Trypanosoma brucei. It threatens over 60 million people in 36 countries of sub-Saharan Africa. There are no effective vaccines and satisfactory drugs for its treatment. Dr. Su and T. brucei biologist Dr. Bibo Li will work together to develop new small molecule drugs to treat this neglected disease.
November 21, 2012:
Congratulations to GRHD members for recently receiving a Federal grant (NIH/NCRR) titled "Nikon A1RSI Confocal Microscope" (PI: Dr. Sailen Barik; Major Users: Drs. Bibo Li, Barsanjit Mazumder, Xue-Long Sun, Roman Kondratov).
This high-power microscope, capable of capturing still and video images in fully programmed mode, will allow studies of cellular structures and their behavior in great detail and clarity.
September 23, 2011:
Dr. Roman Kondratov's funding success and his breakthrough research have been featured in Crain's Cleveland Business
The Cleveland State researcher won a $1.5 million grant to study the aging process. Dr. Kondratov will examine the effects of circadian clocks on aging under dietary restriction. Circadian rhythms are 24-hour internal cycles found in many living organisms. Read more
September 19, 2011:
Congratulations to GRHD member Dr. Valentin Boerner for winning a three-year R15 Federal grant (NIH) to study "Control of pairing and recombination during meiosis".
Dr. Boerner is an expert in the mechanism of chromosome segregation during gamete formation, a key factor for reproductive health in humans.
September 15, 2011:
Congratulations to GRHD member Dr. Roman Kondratov for winning a $1.4 million 5-year Federal (NIH) R01 grant to study "Circadian clock and dietary restriction".
Dietary restriction is powerful intervention that delays the development of age-associated pathologies and increases lifespan in many organisms including humans. Dr. Kondratov's laboratory studies the molecular mechanisms of dietary restriction and its interaction with the circadian clock.
September 14, 2011:
Congratulations to our newest GRHD member, Dr. Andrew Resnick, for receiving an NIH AREA award (R15) titled "Fluid flow may be an environmental modifier of ADPKD disease progression".
Research in his project will shed light on the autosomal dominant Polycystic Kidney Disease, which affects 1 in 1000 Americans, and for which no cure currently exists (http://kidney.niddk.nih.gov/kudiseases/pubs/polycystic/).
August 24, 2011:
Congratulations to GRHD member Dr. Aimin Zhou for winning a two-year R15 Federal grant (NIH) to study "The role of RNase L in the pathogenesis of inflammatory bowel diseases".
Dr. Zhou is an expert in RNase L, an important player in our body's defence against viruses, inflammation, and cancer. In the recent past, three other GRHD members, Drs. Mazumder, Sun and Li, also won large NIH grants
. Together, these highly competitive awards recognize and consolidate GRHD's overall mission to understand and cure human ailments through modern biomedical research.
February 16, 2011:
Congratulations to GRHD member Dr. Bibo Li, recent recipient of a major NIH grant!
Kudos and congratulations to our GRHD member, Dr. Bibo Li, for recently receiving a five-year NIH award totaling $1.8 million to continue her groundbreaking studies to understand how the Trypanosome parasite changes its surface proteins, which allows it to evade human immunity and cause African Trypanosomiasis, a fatal disease if left untreated. Dr. Li's success in this highly competitive field reflects the outstanding quality of research at GRHD. Of note, the 12 GRHD scientists, including Dr. Li, have collectively attracted roughly $11 million of external funding from various sources since 2000 to support cutting-edge biomedical research.
October 25, 2010:
October 8, 2008: